Financial reports
10-K
2023 FY
Annual report
28 Feb 24
10-Q
2023 Q3
Quarterly report
7 Nov 23
10-Q
2023 Q2
Quarterly report
1 Aug 23
10-Q
2023 Q1
Quarterly report
9 May 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
10-K
2022 FY
Annual report
27 Feb 23
10-Q
2022 Q3
Quarterly report
2 Nov 22
10-Q
2022 Q2
Quarterly report
8 Aug 22
10-Q
2022 Q1
Quarterly report
2 May 22
10-K
2021 FY
Annual report
25 Feb 22
Current reports
8-K
Departure of Directors or Certain Officers
12 Apr 24
8-K
Results of Operations and Financial Condition
28 Feb 24
8-K
Gene Therapy for the Treatment of Huntington’s Disease
19 Dec 23
8-K
Departure of Directors or Certain Officers
17 Nov 23
8-K
Results of Operations and Financial Condition
7 Nov 23
8-K
Cost Associated with Exit or Disposal Activities
5 Oct 23
8-K
Results of Operations and Financial Condition
1 Aug 23
8-K
Regulation FD Disclosure
22 Jun 23
8-K
Submission of Matters to a Vote of Security Holders
16 Jun 23
8-K
Entry into a Material Definitive Agreement
16 May 23
Registration and prospectus
S-8
Registration of securities for employees
28 Feb 24
S-8
Registration of securities for employees
8 Dec 23
S-8
Registration of securities for employees
27 Feb 23
S-8
Registration of securities for employees
20 Jul 21
424B5
Prospectus supplement for primary offering
2 Mar 21
S-3ASR
Automatic shelf registration
1 Mar 21
424B5
Prospectus supplement for primary offering
2 Mar 20
424B5
Prospectus supplement for primary offering
6 Sep 19
424B5
Prospectus supplement for primary offering
4 Sep 19
S-8
Registration of securities for employees
14 Jun 18
Proxies
DEFA14A
Additional proxy soliciting materials
24 Apr 24
DEF 14A
Definitive proxy
24 Apr 24
PRE 14A
Preliminary proxy
12 Apr 24
DEFA14A
Additional proxy soliciting materials
6 Oct 23
DEF 14A
Definitive proxy
6 Oct 23
DEFA14A
Additional proxy soliciting materials
28 Apr 23
DEF 14A
Definitive proxy
28 Apr 23
PRE 14A
Preliminary proxy
18 Apr 23
DEF 14A
Definitive proxy
29 Apr 22
PRE 14A
Preliminary proxy
19 Apr 22
Other
CT ORDER
Confidential treatment order
29 Jun 21
SEC STAFF
SEC staff action: Order
5 Mar 20
SEC STAFF
SEC staff action: Order
6 Feb 20
UPLOAD
Letter from SEC
26 Nov 19
CORRESP
Correspondence with SEC
22 Nov 19
UPLOAD
Letter from SEC
7 Nov 19
CT ORDER
Confidential treatment order
11 Apr 19
CT ORDER
Confidential treatment order
21 Feb 19
CT ORDER
Confidential treatment order
4 Dec 17
CT ORDER
Confidential treatment order
3 Oct 17
Ownership
4
Matthew C Kapusta
5 Mar 24
4
CHRISTIAN KLEMT
5 Mar 24
4
Walid Abi-Saab
5 Mar 24
4
PIERRE CALOZ
5 Mar 24
4
Jeannette Potts
5 Mar 24
4
PIERRE CALOZ
28 Feb 24
4
CHRISTIAN KLEMT
28 Feb 24
4
Matthew C Kapusta
28 Feb 24
144
Notice of proposed sale of securities
26 Feb 24
144
Notice of proposed sale of securities
26 Feb 24